On April 25 Apple was granted yet another patent for a Blood Pressure Monitoring System. Other Apple patents relating to blood pressure systems could be review here: 01, 02, 03, 04 and 05. In a race to bring this market, ASUS announced today that their blood pressure applications for their smartwatch had been approved by Taiwan's Food and Drug Administration (TFDA) of the Ministry of Health and Welfare, and has obtained a medical device software license (Ministry of Health Medical Devices No. 007812).

It's being reported this morning by Taiwan's United Daily News that in the future, users of the ASUS VivoWatch series of smart health watches can not only monitor personal blood pressure changes through this function, but the measurement results can also provide medical personnel with blood pressure trend reference for routine examination.

Xie Mingjie, Chief Operating Officer of ASUS Computer and Global Senior Vice President, said, "ASUS R&D team is committed to forward-looking algorithms and integrating software and hardware equipment, and follows the purpose of the medical material industry-putting user safety and product effectiveness as the first consideration, complete experience Product design, technology research and development, medical material evidence collection and other development processes are expected to become a perfect example of an ICT factory, assisting Taiwan's medical industry to continue to shine in the international market with high-quality, high-tech advantages."

The "ASUS Blood Pressure Application Software" for mobile devices can be used with the compatible ASUS VivoWatch to create, record, store, and display blood pressure trend information, and measure the wearer's systolic and diastolic blood pressure; users This function can be enabled by updating ASUS HealthConnect. The updated version of ASUS VivoWatch 5 / SP has been officially launched in Google Play Store and Apple Store; ASUS VivoWatch 5 AERO is expected to be released by the end of this month.

"ASUS Blood Pressure Application Software" uses the time difference of signals collected by VivoWatch's exclusive fingertip electrical/optical dual sensors to calculate the flow rate of blood in the arteries and the pressure of the blood vessel walls when the heart beats; according to internal tests, The accuracy is more than 12% better than that of a single sensor, and it also complies with international standards for non-invasive blood pressure monitors such as AAMI / ANSI / ISO 81060-2.

According to the survey by the National Health Service of the Ministry of Health and Welfare, the prevalence rate of hypertension among people over the age of 20 in China is 24%, with an average of 1 in 4 people suffering from high blood pressure, and as many as 37% of hypertensive patients do not know that their blood pressure is too high High; therefore, in addition to a regular lifestyle, salt reduction, weight loss, and exercise, regular blood pressure measurement will enable early detection of abnormalities, reduce the risk of cardiovascular disease and stroke, and maintain good health.